Table 1.
Clinical Characteristics of the Two COVID-19 Cohorts
| COVIDstable (n = 20) | COVIDICU (n = 20) | Total (n = 40) | |
|---|---|---|---|
| Age, yr | 56.6 ± 17.3 | 54.3 ± 18.2 | 55.5 ± 17.7 |
| Sex, M/F | 12/8 | 13/7 | 25/15 |
| Days since onset of symptoms | 7.00 ± 0.58 | 7.05 ± 0.81 | 7.03 ± 0.74 |
| Symptoms at admission | |||
| Fever | 17 (85) | 18 (90) | 35 (88) |
| Dyspnea | 11 (55) | 15 (75) | 26 (65) |
| Cough | 11 (55) | 14 (70) | 25 (60) |
| Sputum production | 5 (25) | 5 (25) | 10 (25) |
| Myalgia | 8 (40) | 7 (35) | 15 (38) |
| Sore throat | 5 (25) | 4 (20) | 9 (23) |
| Nasal congestion | 1 (5) | 0 (0) | 1 (3) |
| Headache | 6 (30) | 5 (25) | 11 (28) |
| Fatigue | 13 (65) | 14 (70) | 13 (68) |
| Anorexia | 5 (25) | 6 (30) | 11 (28) |
| Nausea | 5 (25) | 5 (25) | 10 (25) |
| Vomiting | 0 (0) | 1 (5) | 1 (3) |
| Diarrhea | 4 (20) | 3 (15) | 7 (18) |
| Chest pain | 6 (30) | 6 (30) | 6 (30) |
| Anosmia | 4 (20) | 3 (15) | 7 (18) |
| Circumstances surrounding infection | |||
| Recent travel to high-risk area | 4 (20) | 2 (10) | 6 (15) |
| Close contact with infected person | 8 (40) | 10 (50) | 18 (45) |
| Community acquired | 8 (40) | 8 (40) | 16 (40) |
| Comorbidities | |||
| Hypertension | 8 (40) | 8 (40) | 16 (40) |
| Coronary artery disease | 4 (20) | 3 (15) | 7 (18) |
| Diabetes mellitus | 4 (20) | 4 (20) | 8 (20) |
| Obesity | 13 (65) | 14 (70) | 27 (68) |
| Chronic lung disease | 6 (30) | 5 (25) | 11 (28) |
| Chronic kidney disease | 5 (25) | 4 (20) | 9 (23) |
| Smoking history | |||
| Current | 6 (30) | 6 (30) | 12 (30) |
| Former | 4 (20) | 4 (20) | 8 (20) |
| Never | 10 (50) | 10 (50) | 20 (50) |
| Vaping history | |||
| Current | 3 (15) | 2 (10) | 5 (13) |
| Former | 0 (0) | 0 (0) | 0 (0) |
| Never | 17 (85) | 18 (90) | 35 (88) |
Definition of abbreviations: COVID-19 = coronavirus disease; COVIDICU = patients with COVID-19 requiring ICU admission; COVIDstable = hospitalized but stable patients with COVID-19.
Data are presented as mean ± SD or absolute number (percentage of group total).